Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00708955 · ClinicalTrials.gov registry record
Evaluation and Treatment of People With Eye Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 2,164
- Enrollment target
NCT00708955: Completed study, sponsored by National Eye Institute (NEI).
NCT00708955 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 2,164 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00708955 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 2,164 participants
- Enrollment target
Study Summary
This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye Institute and will allow institute specialists the opportunity to maintain their expertise and gain additional knowledge of the course of various eye disorders. The information obtained will allow for the evaluation of standard treatments and may lead to ideas for future research. People with diagnosed or undiagnosed eye disease and first-degree relatives of people with a genetic or developmental eye disease may be eligible for this study. Participants are evaluated and treated in the National Eye Institute. Blood or other tissue samples (e.g., urine, stool, hair, saliva or cheek swab) may be collected for future laboratory studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,164 participants |
| Start Date | 2008-06-25 |
| Est. Completion | 2017-07-12 |
What the finished NCT00708955 record still lists
NCT00708955 is an observational study that tracks outcomes without assigning an intervention. Its 2,164 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00708955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00708955 about?
NCT00708955 is a clinical study titled "Evaluation and Treatment of People With Eye Diseases". This study will evaluate and provide standard treatments for people with various eye conditions. It will provide a resource for enrollment into new research protocols throughout the Eye Institute and will allow institute specialists the opportunity to maintain their expertise and gain additional kno...
What is the current status of trial NCT00708955?
This trial is currently completed. The enrollment target is 2,164 participants. The study started on 2008-06-25. Estimated completion is 2017-07-12.
Who is sponsoring clinical trial NCT00708955?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05742178 · 2,160 participants · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI